Meet The Team

Dr Kimberly Rockley

PhD

Kimberly Rockley leads the microelectrode (MEA) hiPSC-methods team and conducts MEA seizure liability studies for clients. Kim developed our iSLA (in vitro seizure liability assay) for which she has received a number of accolades including the BioNow Rising Star award in 2022. She holds a PhD in Pharmacy from Durham University where she used novel in vitro methods to investigate anthracycline-induced cardiotoxicity and its mitigation by perturbation of angiotensin signalling. Kim is passionate about the use of in vitro techniques to improve preclinical safety and reduce animal testing.